Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia.
Mohammad Ali Esmaili(Shahid Beheshti University of Medical Sciences), Mohammad Reza Rezvany(Karolinska University Hospital), Mohammad Faranoush(Iran University of Medical Sciences), Håkan Mellstedt(Karolinska University Hospital), Ahmad Kazemi(Iran University of Medical Sciences), Majid Safa(Iran University of Medical Sciences), Farhad Zaker(Iran University of Medical Sciences), Narjes Mehrvar(Shahid Beheshti University of Medical Sciences)
Cited by 28
Related Papers
The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
|PLoS ONE|2013|60
Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
|PLoS ONE|2013|58
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
|Biomarker Research|2023|48
Overexpression of Orphan Receptor Tyrosine Kinase <i>Ror1</i> as a Putative Tumor-Associated Antigen in Iranian Patients with Acute Lymphoblastic Leukemia
|Tumor Biology|2007|46
Expression profile of orphan receptor tyrosine kinase (<i>ROR1</i>) and Wilms' tumor gene 1 (<i>WT1</i>) in different subsets of B-cell acute lymphoblastic leukemia
|Leukemia & lymphoma/Leukemia and lymphoma|2008|46